House Call: Alternatives for IBD Patients

Dr. David Rubin discusses what IBD patients can do if they are asked to stop immunosuppressant treatment because of COVID-19.

Inflammatory bowel disease (IBD) patients who contract the coronavirus disease 2019 (COVID-19) are recommended to halt their immunosuppressant treatments, but what alternatives do they have to not worsen the IBD condition?

In an interview with HCPLive®, David T. Rubin, MD, University of Chicago Medicine Inflammatory Bowel Disease Center, discusses some of the options for these patients and what researchers have learned about how COVID-19 results in some gastrointestinal symptoms.